Question: Which HCPCS code should I use to report Eovist MRI contrast?
Answer: You should verify the appropriate code with your payer, but the most likely option is A9579 (Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified [NOS], per ml).
Here’s why: HCPCS doesn’t currently offer a specific Eovist (gadoxetate disodium) code for physician claims. (Code C9246 [Injection, gadoxetate disodium, per ml] does describe Eovist, but HCPCS guidelines state that C codes “can only be reported for facility [technical] services.”)
Because you don’t have a specific HCPCS code for your physician claim, you should choose a “not otherwise specified” code. CIGNA Government Services, the Part B carrier for North Carolina, for example, lists Eovist on its “Not Otherwise Classified Drug” Part B Fee Schedule under Option 3.
Eovist, used specifically to detect lesions in the liver, is a gadolinium-based magnetic resonance contrast agent, making it a match for code A9579. Remember to include on the claim the drug’s name and exact dosage given.
Potential new code: Eovist had a spot on the April 2009 HCPCS Public Meeting agenda. There was a request for a specific code, and CMS’s preliminary decision was that it would create Axxxx (Injection, gadoxetate disodium, 1ml). We’ll keep you posted.
- Free updates on CPT, ICD-9, HCPCS, Medicare, NCCI edits, and ICD-10.
- Discounts on 3rd party offers